---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-027826"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:48:44.255121+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Aadi Bioscience shareholders approve director elections, say-on-pay, and auditor ratification at 2024 annual meeting

## Summary
- Elected Caley Castelein (9.95M for, 1.91M withheld) and Neil Desai (8.17M for, 3.68M withheld) as Class I directors.
- Advisory vote on executive compensation passed with 8.97M for, 2.60M against, 282K abstentions.
- Ratified BDO USA as independent auditor for FY 2024: 13.46M for, 635K against, 1.00M abstentions.
- Total shares represented 15.1M, ~62% of voting power, establishing a quorum.

## SEC filing metadata
- accession: 0001628280-24-027826
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000162828024027826/0001628280-24-027826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000162828024027826/aadi-20240611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-027826
- JSON: https://secwatch.observer/filing/0001628280-24-027826.json
- Plain text: https://secwatch.observer/filing/0001628280-24-027826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.